Short- and Mid-Term Outcomes of Endovascular Stenting for the Treatment of Post-Thrombotic Syndrome due to Iliofemoral and Caval Occlusive Disease: A Multi-Centric Study from the French Society of Diagnostic and Interventional Cardiovascular Imaging (SFICV)

Author(s):  
Arthur David ◽  
Frédéric Thony ◽  
Costantino Del Giudice ◽  
Gilles Goyault ◽  
Romaric Loffroy ◽  
...  
2017 ◽  
Vol 98 (3) ◽  
pp. 203-215 ◽  
Author(s):  
Y. Cruypeninck ◽  
B. Dubourg ◽  
P. Michelin ◽  
B. Godin ◽  
C. Savoye-Collet ◽  
...  

2016 ◽  
Vol 2 ◽  
pp. 353-359 ◽  
Author(s):  
Rimantas Benetis ◽  
Zana Kavaliauskiene ◽  
Aleksandras Antusevas ◽  
Rytis Stasys Kaupas ◽  
Donatas Inciura ◽  
...  

2019 ◽  
Vol 58 (6) ◽  
pp. e208-e209
Author(s):  
Niall Hardy ◽  
Zenia Martin ◽  
Prakash Madhavan ◽  
Sean O'Neill ◽  
Mary Paula Colgan ◽  
...  

2014 ◽  
Vol 29 (1_suppl) ◽  
pp. 104-111 ◽  
Author(s):  
FS Catarinella ◽  
FHM Nieman ◽  
MAF de Wolf ◽  
CHA Wittens

Introduction Treatment of deep venous occlusive disease is gaining popularity, although the results and outcomes of various techniques are yet to be fully studied. Quality-of-Life (QoL) improvement is a valid and important outcome in medicine, but no specific QoL instruments for deep venous pathology exist up until now. We assessed the short term QoL effects of treated patients with post thrombotic syndrome after deep venous occlusion. Materials and methods Patients with proven venous occlusive disease referred to the outpatient clinic of our department of Venous Surgery in the Maastricht University Medical Centre were included. After inclusion, patients were treated by PTA and stenting and when indicated an endophlebectomy was performed and an AV fistula was made. QoL was assessed with the disease specific VEINES-QOL/Sym and the generic SF-36 questionnaires preoperatively at baseline and postoperatively at 3 and 12 months. Results 61 patients completed the 3 month follow-up period and 28 patients the 12 month follow-up period. VEINES-QOL and Sym scores improved after 3 months: 17.5 points for QOL (p = < 0.001) and 21.4 points for Sym (p = < 0.001)) and after 12 months 18.8 points for QOL (p = 0.004) and 21.3 points for Sym (p = 0.003)). The SF-36 scores improved significantly in the domains “physical functioning”, “role physical” and “bodily pain”. Conclusions Treating deep venous occlusive disease leads to short-term improvement of both disease specific QoL as well as generic QoL scores. Larger long-term follow-up studies are needed to corroborate these results.


2000 ◽  
Vol 111 (4) ◽  
pp. 1122-1129 ◽  
Author(s):  
R. Chopra ◽  
J. D. Eaton ◽  
A. Grassi ◽  
M. Potter ◽  
B. Shaw ◽  
...  

VASA ◽  
2016 ◽  
Vol 45 (2) ◽  
pp. 141-147 ◽  
Author(s):  
Jakob Martin Burgstaller ◽  
Johann Steurer ◽  
Ulrike Held ◽  
Beatrice Amann-Vesti

Abstract. Background: Here, we update an earlier systematic review on the preventive efficacy of active compression stockings in patients with diagnosed proximal deep venous thrombosis (DVT) by including the results of recently published trials. The aims are to synthesize the results of the original studies, and to identify details to explain heterogeneous results. Methods: We searched the Cochrane Library, PubMed, Scopus, and Medline for original studies that compared the preventive efficacy of active compression stockings with placebo or no compression stockings in patients with diagnosed proximal DVT. Only randomized controlled trials (RCTs) were included. Results: Five eligible RCTs with a total of 1393 patients (sample sizes ranged from 47 to 803 patients) were included. In three RCTs, patients started to wear compression stockings, placebo stockings or no stockings within the first three weeks after the diagnosis of DVT. The results of two RCTs indicate a statistically significant reduction in post-thrombotic syndrome (PTS) of 50% or more after two or more years. The result of one RCT shows no preventive effect of compression stockings at all. Due to the heterogeneity of the study results, we refrained from pooling the results of the RCTs. In a further RCT, randomization to groups with and without compression stockings took place six months after the diagnosis of DVT, and in another RCT, only patients with the absence of PTS one year after the diagnosis of DVT were analyzed. One RCT revealed a significant reduction in symptoms, whereas another RCT failed to show any benefit of using compression stockings. Conclusions: At this time, it does not seem to be justifiable to entirely abandon the recommendations regarding compression stockings to prevent PTS in patients with DVT. There is evidence favoring compression stockings, but there is also evidence showing no benefit of compression stockings.


Sign in / Sign up

Export Citation Format

Share Document